▼ PLUNGE

Eterna Therapeutics Inc.

-22.3%
ERNANASDAQHealthcare2026-04-30
0.148
收盘价
0.19
前收盘价
-22.32%
涨幅
15.2x
量比

暴跌原因

没有相关新闻。

相关新闻

Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria
Weeklyvoice2026-04-13
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan2026-04-06
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus2026-04-06
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
Weeklyvoice2026-04-06
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular ...
Postregister2026-04-16

技术分析

信号
布林下轨突破超卖MACD看跌跌破SMA20
关键指标
24.14RSI (14)
0.20SMA 20
0.17Bollinger Lower
0.23Bollinger Upper
0.20Bollinger Mid
-0.02MACD
-0.02MACD Signal
0.00MACD Hist
查看股票详情返回暴涨股列表
Eterna Therapeutics Inc. +-22.3% 暴涨分析 (2026-04-30) | Alpha Lenz